Literature DB >> 29102656

PCSK9 antagonists and inflammation.

Massimiliano Ruscica1, Nicola Ferri2, Alberto Corsini3, Cesare R Sirtori4.   

Abstract

Entities:  

Keywords:  Inflammation; PCSK9

Mesh：

Substances：

Year:  2017        PMID： 29102656     DOI： 10.1016/j.atherosclerosis.2017.10.022

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN： 0021-9150            Impact factor:   5.162


× No keyword cloud information.
  4 in total

1.  Statins and C-reactive protein: in silico evidence on direct interaction.

Authors:  Neda Shakour; Massimiliano Ruscica; Farzin Hadizadeh; Cesare Cirtori; Maciej Banach; Tannaz Jamialahmadi; Amirhossein Sahebkar
Journal:  Arch Med Sci       Date:  2020-11-02       Impact factor: 3.318

2.  PCSK9 mediates the oxidative low‑density lipoprotein‑induced pyroptosis of vascular endothelial cells via the UQCRC1/ROS pathway.

Authors:  Junfa Zeng; Jun Tao; Linzhen Xi; Zuo Wang; Lushan Liu
Journal:  Int J Mol Med       Date:  2021-02-12       Impact factor: 4.101

Review 3.  Anti-inflammatory Treatment and Cardiovascular Outcomes: Results of Clinical Trials.

Authors:  Alberto J Lorenzatti
Journal:  Eur Cardiol       Date:  2021-04-23

4.  Functional Crosstalk between PCSK9 Internalization and Pro-Inflammatory Activation in Human Macrophages: Role of Reactive Oxygen Species Release.

Authors:  Rafael I Jaén; Adrián Povo-Retana; César Rosales-Mendoza; Patricia Capillas-Herrero; Sergio Sánchez-García; Paloma Martín-Sanz; Marina Mojena; Patricia Prieto; Lisardo Boscá
Journal:  Int J Mol Sci       Date:  2022-08-14       Impact factor: 6.208
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.